Anthracenes
-
Subject Areas on Research
- A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling.
- Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo.
- Aminoanthracene is a mechanism-based inactivator of CYP1A in channel catfish hepatic tissue.
- Anthracenedione activation by NADPH-cytochrome P-450 reductase; comparison with anthracyclines.
- Cross-reaction to maprotiline.
- Evaluating the mycostimulation potential of select carbon amendments for the degradation of a model PAH by an ascomycete strain enriched from a superfund site.
- Evaluation of arylmethylaminopropanediols by a novel in vitro pharmacodynamic assay: correlation with antitumor activity in vivo.
- Human lung innate immune response to Bacillus anthracis spore infection.
- Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
- Induction of hepatic CYP1A in channel catfish increases binding of 2-aminoanthracene to DNA in vitro and in vivo.
- Laser-induced fluorescence studies of polycyclic aromatic hydrocarbons (PAH) vapors at high temperatures.
- Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase.
- Modulating unimolecular charge transfer by exciting bridge vibrations.
- Oxygen-containing functional groups on single-wall carbon nanotubes: NEXAFS and vibrational spectroscopic studies
- Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule.
- Phototoxicity in human retinal pigment epithelial cells promoted by hypericin, a component of St. John's wort.
- The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury.
- c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes.